- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05721183
Evaluation of the National Tool for Observation of Infection Prevention Measures in the Healthcare (NOST)
Evaluation of the National Tool for Observation of Infection Prevention Measures in the Healthcare (NOST) - a Cluster Randomized Trial
The Norwegian Institute of Public Health (NIPH) is introducing a new electronic tool for direct observation of compliance with recommended infection prevention and control measures in healthcare. The solution is called the National Tool for Observation of Infection Prevention Measures (NOST). NOST is a quality improvement tool that includes a web-based solution for observing compliance with recommendations for hand hygiene and other IPC measures. Through NOST, healthcare personnel will be able to identify the local level of compliance, which in turn can reveal areas for improvement.
This protocol includes the evaluation of NOST in hospitals. The evaluation is designed as a cluster-randomized controlled trial with two arms where eligible wards in hospitals are randomly allocated into an intervention and a control arm. NOST is implemented in the intervention wards at the start of the evaluation period, and compliance with hand hygiene and other outcomes are measured in both the interventions and control wards one year later.
The objective of evaluating NOST is to:
- measure if implementation of NOST leads to improved infection prevention and control in the form of increased compliance with hand hygiene recommendations, and
- measure if changes in the quality of infection prevention and control as a result of implemented NOST affects the epidemiology of healthcare-associated infections in healthcare institutions and the length of hospital stays.
Study Overview
Status
Intervention / Treatment
Detailed Description
The evaluation og NOST is designed as a cluster-randomized controlled trial with two arms where eligible wards in hospitals are randomly allocated into an intervention and a control arm. NOST is implemented in the intervention wards at the start of the evaluation period, and compliance with hand hygiene and other outcomes are measured in both the interventions and control wards one year later.
Intervention
The intervention in the study is to implement NOST, which includes:
- observation and recording of compliance with hand hygiene recommendations
- identification of areas for improvement
- training or other actions taken to improve IPC in general or compliance with hand hygiene.
Thus, the intervention includes both observation of compliance and any additional improvement measures initiated as a result of the introduced NOST.
Observations of hand hygiene will be carried out in sessions of 20-30 minutes. During this period, all situations where hand hygiene is indicated (recommended) and whether hand hygiene is performed or not, are recorded. The number of hand hygiene indications during a session varies but will often be between 10 and 20.
When the intervention group has implemented and followed NOST for a year, the investigators will measure compliance with hand hygiene recommendations and reported HAIs, in wards that have had NOST and in wards that have not introduced NOST.
The intervention arm will be followed over time with repeated measurements of both compliance with hand hygiene and other outcome measures, to see if the effect increases in line with implemented observations and quality improvement measures, or if the effect decreases during the study period.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0213
- Norwegian Institute of Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hospital wards with day- and night care.
Exclusion Criteria:
- Intensivecare units.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NOST
The intervention is to implement NOST, which includes: observation and recording of compliance with hand hygiene recommendations identification of areas for improvement training or other actions taken to improve IPC in general or compliance with hand hygiene. Thus, the intervention includes both observation of compliance and any additional improvement measures initiated as a result of the introduced NOST. When the intervention group has implemented and followed NOST for a year, the investigators will measure compliance with hand hygiene recommendations and reported HAIs, in wards that have had NOST and in wards that have not introduced NOST. The intervention arm will be followed over time with repeated measurements of both compliance with hand hygiene and other outcome measures, to see if the effect increases in line with implemented observations and quality improvement measures, or if the effect decreases during the study period. |
The intervention is to implement NOST, which includes: observation and recording of compliance with hand hygiene recommendations identification of areas for improvement training or other actions taken to improve IPC in general or compliance with hand hygiene. Thus, the intervention includes both observation of compliance and any additional improvement measures initiated as a result of the introduced NOST. When the intervention group has implemented and followed NOST for a year, the investigators will measure compliance with hand hygiene recommendations and reported HAIs, in wards that have had NOST and in wards that have not introduced NOST. The intervention arm will be followed over time with repeated measurements of both compliance with hand hygiene and other outcome measures, to see if the effect increases in line with implemented observations and quality improvement measures, or if the effect decreases during the study period. |
No Intervention: Control
Participants in the no intervention arm arm are asked not to implement NOST.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hand hygiene observations
Time Frame: Day 1 to one year later
|
Self-reported proportion of correct compliance, in total and by occupation
|
Day 1 to one year later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outbreaks of infectious diseases
Time Frame: Day 1 to one year later
|
Proportion of outbreaks per ward and secondary attack rate by inpatients and staff.
Data collected from VESUV
|
Day 1 to one year later
|
Surveillance of healthcare-associated infections
Time Frame: Day 1 to one year later
|
Proportion of infected inpatients by type of infections.
Data collected from NOIS
|
Day 1 to one year later
|
Surveillance of postoperative site infections
Time Frame: Day 1 to one year later
|
Proportion of infected patients by type of surgery and type of infections.
Data collected from NOIS and POSI
|
Day 1 to one year later
|
Length of stay
Time Frame: Day 1 to one year later
|
Mean and median bed-days per stay.
Data collected from NRP
|
Day 1 to one year later
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOST
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections, Respiratory
-
GlaxoSmithKlineCompletedInfections, Respiratory Syncytial VirusCanada
-
GlaxoSmithKlineCompletedInfections, Respiratory Syncytial VirusUnited States
-
University of DerbySheffield Hallam University; University Hospitals of Derby and Burton NHS Foundation...CompletedRespiratory Muscle | Infections, Respiratory | Respiratory Physiology | Symptoms and General PathologyUnited Kingdom
-
University of Alabama at BirminghamRecruitingRespiratory Syncytial Virus InfectionsUnited States
-
University Hospital Southampton NHS Foundation...University College, London; Bill and Melinda Gates FoundationCompletedRespiratory InfectionsUnited Kingdom
-
University of EdinburghNHS LothianCompletedRespiratory InfectionsUnited Kingdom
-
PfizerRecruitingRespiratory Syncytial Virus InfectionsUnited States, Israel, Korea, Republic of, Japan, Canada
-
University Hospital, Strasbourg, FranceCompletedSARS (Severe Acute Respiratory Syndrome)France
-
Duke UniversityBiomedical Advanced Research and Development AuthorityEnrolling by invitationRespiratory Syncytial Virus Infections | COVID-19 Respiratory Infection | Influenza Viral Infections | Rhinoviral InfectionsUnited States
-
University of EdinburghNHS LothianCompleted